Stifel Financial’s Impax Laboratories, Inc. IPXL Stock Holding History

Stifel Financial’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-598,083	Closed	-$11.7M	–	2833
2018 Q1	$11.7M	Sell	598,083 -106,445	-15%	-$2.09M	0.04%	476
2017 Q4	$11.8M	Buy	704,528 +14,597	+2%	+$268K	0.04%	461
2017 Q3	$14M	Buy	689,931 +53,068	+8%	+$1.01M	0.05%	381
2017 Q2	$10.3M	Buy	+636,863	New	+$9.41M	0.04%	470

Stifel Financial's IPXL Position: Q2 2018 in Review

Stifel Financial sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 598,083 shares — an estimated $11.7M sold.

Stifel Financial first reported a position in IPXL in Q2 2017 and held it in 4 quarters. The position peaked at $14M in Q3 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Stifel Financial reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Stifel Financial sold 598,083 Impax Laboratories, Inc. shares in Q2 2018, an estimated $11.7M.
Stifel Financial first reported a position in Impax Laboratories, Inc. in Q2 2017 and held it in 4 quarters.
Stifel Financial's Impax Laboratories, Inc. position peaked at $14M in Q3 2017.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Stifel Financial's 13F filing for Q2 2018, filed 14 Aug 2018.